Foghorn Therapeutics Inc. develops gene controlling therapies. It owns and operates Gene Traffic Control, a platform that directs which genes cells express, and when, where, and in what order.
Foghorn Therapeutics
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttps://foghorntx.com
Founded2016
Disease Focus
Development Stage
STOCK CODENon Listed
Address161 First Street, Suite 2A/2B, MA 2142CambridgeUnited States
161 First Street, Suite 2A/2B, MA 2142
Cambridge
United States
Contact Number+1 617 586 3100
+1 617 586 3100
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/foghorn-therapeutics” connections=”true” suffix=””]